(Medicare National Coverage Determinations Manual)

Medicare National Coverage Determinations Manual Crosswalk CIM to NCD Sections The column on the far right (column 3) is in CIM sequence. Column 1 shows the NDC Manual section.  Note that the sections in the NCD are in CPT category sequence and not in Medicare benefit category sequence.  NCD Section Title CIM Section  310.1 Routine Costs in Clinical Trails CIM 30-1 10.8.1 Stem Cell Transplantation CIM 35.30.1 100.7 Colonic Irrigation CIM 35-1 20.29 Hyperbaric Oxygen Therapy CIM 35-10 80.2 Photodynamic Therapy CIM 35-100 250.4 Treatment of Actinic Keratosis CIM 35-101 160.25 Multiple Electroconvulsive Therapy (MECT) CIM 35-103 260.5 Intestinal and Multivisceral Transplantation CIM 35-104 230.3 Sterilization CIM 35-11 140.4 Plastic Surgery to Correct "Moon Face" CIM 35-12 150.7 Prolotherapy; Joint Sclerotherapy, and Ligamentous Injections with Sclerosing Agents CIM 35-13 70.1 Consultations With a Beneficiarys Family and Associates CIM 35-14 240.7 Postural Drainage Procedures and Pulmonary Exercises CIM 35-15 80.11 Vitrectomy CIM 35-16 160.1 Induced Lesions of Nerve Tracts CIM 35-17 30.4 Electrosleep Therapy CIM 35-18 30.6 Intravenous Histamine Therapy CIM 35-19 NCD Section Title CIM Section  150.1 Manipulation CIM 35-2 160.2 Treatment of Motor Function Disorders with Electric Nerve Stimulation CIM 35-20 10.3 Inpatient Hospital Pain Rehabilitation Programs CIM 35-21 10.4 Outpatient Hospital Pain Rehabilitation Programs CIM 35-21.1 130.1 Inpatient Hospital Stays for the Treatment of Alcoholism CIM 35-22 130.2 Outpatient Hospital Services for Treatment of Alcoholism CIM 35-22 130.6 Treatment of Drug Abuse (Chemical Dependency) CIM 35-22.2 130.5 Treatment of Alcoholism and Drug Abuse in a Freestanding Clinic CIM 35-22.3 130.3 Chemical Aversion Therapy for Treatment of Alcoholism CIM 35-23 130.4 Electrical Aversion Therapy for Treatment of Alcoholism CIM 35-23.1 230.4 Diagnosis and Treatment of Impotence CIM 35-24 20.10 Cardiac Rehabilitation Programs CIM 35-25 40.5 Treatment of Obesity CIM 35-26 30.1 Biofeedback Therapy CIM 35-27 30.1.1 Biofeedback Therapy For The Treatment Of Urinary Incontinence CIM 35-27.1 50.5 Oxygen Treatment of Inner Ear/Carbon Therapy CIM 35-29 240.3 Heat Treatment, Including the Use of Diathermy and Ultra-Sound for Pulmonary Conditions CIM 35-3 110.8 Blood Platelet Transfusions CIM 35-30 NCD Section Title CIM Section  270.4 Treatment Of Decubitus Ulcers CIM 35-31  100.8 Intestinal By-Pass Surgery CIM 35-33 230.2 Uroflowmetric Evaluations CIM 35-33 20.23 Fabric Wrapping of Abdominal Aneurysms CIM 35-34 20.28 Therapeutic Embolization CIM 35-35 20. 01 Vertebral Artery Surgery CIM 35-37 20. 2 Extracranial-Intracranial (EC-IC) Arterial Bypass Surgery CIM 35-37 110.15 Ultrafiltration, Hemoperfusion and Hemofiltration CIM 35-38 80.6 Intraocular Photography CIM 35-39 50.8 Ultrasonic Surgery CIM 35-4 100.1 Gastric Bypass Surgery for Obesity CIM 35-40 150.5 Diathermy Treatment CIM 35-41 130.7 Withdrawal Treatments for Narcotic Addictions CIM 35-42 10.1 Use Of Visual Tests Prior To And General Anesthesia During Cataract Surgery  CIM 35-44 20.25 Cardiac Catheterization Performed in Other Than a Hospital Setting CIM 35-45 160.3 Assessing Patients Suitability for Electrical Nerve Stimulation CIM 35-46 160.7.1 Assessing Patients Suitability for Electrical Nerve Stimulation Therapy CIM 35-46 140.2 Breast Reconstruction Following Mastectomy CIM 35-47 150.2 Osteogenic Stimulator CIM 35-48 160.11 Osteogenic Stimulation  CIM 35-48 NCD Section Title CIM Section  110.1 Hyperthermia for Treatment of Cancer CIM 35-49 30.8 Cellular Therapy CIM 35-5 50.7 Cochleostomy with Neurovascular Transplant for Menieres Disease CIM 35-50 130.8 Hemodialysis for Treatment of Schizophrenia CIM 35-51 140.5 Laser Procedures CIM 35-52 260.1 Adult Liver Transplantation CIM 35-53 260.2 Pediatric Liver Transplantation CIM 35-53.1 80.7 Refractive Keratoplasty CIM 35-54 240.6 Transvenous (Catheter) Pulmonary Embolectomy CIM 35-55 150.8 Fluidized Therapy Dry Heat for Certain Musculoskeletal Disorders CIM 35-56 160.8 Electroencephalographic Monitoring During Surgical Procedures Involving the Cerebral Vasculature CIM 35-57 160.9 Electroencephalographic (EEG) Monitoring During Open-Heart Surgery CIM 35-57.1 20.3 Thoracic Duct Drainage (TDD) In Renal Transplants CIM 35-58 100.2 Endoscopy CIM 35-59 30.2 Thermogenic Therapy CIM 35-6 110.14 Apheresis  (Therapeutic Pheresis) CIM 35-60 140.3 Transsexual Surgery CIM 35-61 160.14 Invasive Intracranial Pressure Monitoring CIM 35-62 50.6 Tinnitus Masking CIM 35-63 20.21 Chelation Therapy for Treatment of AtherosclerosisCIM 35-64 NCD Section Title CIM Section  Atherosclerosis 100.6 Gastric Freezing CIM 35-65 250.1 Treatment of Psoriasis CIM 35-66 170.2 Melodic Intonation Therapy CIM 35-67 100.9 Implantation of Anti-Gastroesophageal Reflux Device CIM 35-69 20.18 Carotid Body Resection/Carotid Body Denervation CIM 35-7 40.3 Closed-Loop Blood Glucose Control Device (CBGCD) CIM 35-70 110.16 Nonselective (Random) Transfusions and Living Related Donor Specific Transfusions (DST) in Kidney Transplantation CIM 35-71 160.15 Electrotherapy for Treatment of Facial Nerve Palsy (Bells Palsy) CIM 35-72 100.10 Injection Sclerotherapy for Esophageal Variceal Bleeding   CIM 35-73 20.20 External Counterpulsation (ECP) for Severe Angina CIM 35-74 20.11 Intraoperative Ventricular Mapping  CIM 35-75 150.4 Neuromuscular Electrical Stimulator (NMES) in the Treatment of Disuse Atrophy CIM 35-77 160.12 Neuromuscular Electrical Stimulation (NMES) in the Treatment of Disuse Atrophy CIM 35-77 20.12 Diagnostic Endocardial Electrical Stimulation (Pacing)    CIM 35-78 10.6 Anesthesia in Cardiac Pacemaker Surgery CIM 35-79 20.8.3 Anesthesia in Cardiac Pacemaker Surgery CIM 35-79 30.3 Acupuncture CIM 35-8 NCD Section Title CIM Section  230.1 Treatment of Kidney Stones CIM 35-81 260.3 Pancreas Transplants CIM 35-82 100.3 24-Hour Ambulatory Esophegeal pH Monitoring CIM 35-83 160.4 Steroetactic Cingulotomy as a Means of Psychosurgery CIM 35-84 20.4 Implantation of Automatic Defibrillators CIM 35-85 100.11 Gastric Balloon for Treatment of Obesity CIM 35-86 260.9 Heart Transplants CIM 35-87 110.4 Extracorporeal Photopheresis CIM 35-88 170.3 Speech Pathology Services for the Treatment of Dysphagia CIM 35-89 80.10 Phaco-Emulsification Procedure  (Cataract Extraction) CIM 35-9 20.5 Extracorporeal Immunoadsorption (ECI) Using Protein A Columns  CIM 35-90 100.13 Laproscopic Cholecystectomy CIM 35-91 30.5 Transcendental Meditation CIM 35-92 240.1 Lung Volume Reduction Surgery (Reduction Pneumoplasty) CIM 35-93 20.6 Transmyocardial Revascularization (TMR) CIM 35-94 20.26 Partial Ventriculectomy CIM 35-95 230.9 Cryosurgery of Prostate CIM 35-96 160.16 Vertebral Axial Decompression (VAX-D) CIM 35-97 270.1 Electrostimulation in the Treatment of Wounds CIM 35-98 140.1 Abortion  CIM 35-99 NCD Section Title CIM Section  160.17 L-Dopa  CIM 45-1 30.7 Laetrile and Related Substances CIM 45-10 10.5 Autogenous Epidural Blood Graft CIM 45-11 270.5 Porcine Skin and Gradient Pressure Dressings CIM 45-12 70.3 Physicians Office Within an Institution  Coverage of Services and Supplies Incident to a Physicians Services CIM 45-15 110.2 Certain Drugs Distributed by the National Cancer Institute CIM 45-16 160.20 Transfer Factor For Treatment of Multiple Sclerosis CIM 45-17 110.5 Granulocyte Transfusions CIM 45-18 10.2 Transcutaneous Electrical Nerve Stimulation (TENS) for Acute Post-Operative Pain CIM 45-19 20.22 Ethylenediamine-Tetra-Acetic (EDTA) Chelation Therapy for Treatment of Atherosclerosis CIM 45-20 110.6 Scalp Hypothermia During Chemotherapy to Prevent Hair Loss CIM 45-21 260.7 Lymphocyte Immune Globulin, Anti-Thymocyte Globulin (Equine) CIM 45-22 230.12 Dimethyl Sulfoxide (DMSO)   CIM 45-23 110.3 Anti-Inhibitor Coagulant Complex (AICC) CIM 45-24 160.13 Supplies Used in the Delivery of Transcutaneous Electrical Nerve Stimulation (TENS) and Neuromuscular Electrical Stimulation (NMES) CIM 45-25 270.3 Platelet-Derived Wound Healing Formula CIM 45-26 110.7 Blood Transfusions CIM 45-27 110.9 Antigens Prepared for Sublingual Administration CIM 45-28 NCD Section Title CIM Section  110.10 Intravenous Iron Therapy CIM 45-29 40.4 Insulin Syringe CIM 45-3 80.3 Photosensitive Drugs CIM 45-30 250.3 Intravenous Immune Globulin For The Treatment Of Autoimmune Mucutaneous Blistering Diseases  CIM 45-31 230.19 Levocarnitine for Use in the Treatment of Carnitine Deficiency in ESRD Patients CIM 45-32 150.6 Vitamin B12 Injections to Strengthen Tendons; Ligaments; etc; of the Foot CIM 45-4 80.1 Hydrophilic Contact Lens for Corneal Bandage CIM 45-7 70.2.1 Services Provided for the Diagnosis and Treatment of Diabetic Sensory Neuropathy with Loss of Protective Sensation (aka Diabetic Peripheral Neuropathy) CIM 50.8.1 20.8.1 Cardiac Pacemaker Evaluation Services CIM 50-1 20.8.1.1 Transtelephonic Monitoring of Cardiac Pacemakers CIM 50-1 230.6 Vabra Aspirator CIM 50-10 220.1 Computerized Tomography  CIM 50-12 220.2 Magnetic Resonance Imaging CIM 50-13  220.3 Magnetic Resonance Angiography CIM 50-14 20.15 Electrocardiographic Services CIM 50-15 250.2 Hemorheograph CIM 50-16 190.4 Electron Microscope CIM 50-18 70.4 Pronouncement of Death CIM 50-19 110.13 Cytotoxic Food Tests CIM 50-2 NCD Section Title CIM Section  190.2 Diagnostic Pap Smears CIM 50-20 230.11 Diagnostic Pap Smears